FDA Issues Warnings Regarding Xeljanz (tofacitinib)
On July 26, the U.S. Food and Drug Administration (FDA) approved new warnings of an increased chance of
Learn MoreDangerous Drugs
FDA Issues Warnings About ‘Uncontrollable Urges’ Associated With Abilify
The U.S. Food and Drug Administration (FDA) has added warnings about “uncontrollable urges” to the drug label and
Learn More
CSS Files Lawsuits on Behalf of Patients Who Developed SJS
Childers, Schlueter & Smith, LLC has recently filed suit for cases in which patients developed Stevens-Johnson Syndrome (SJS)
Learn More
Pathological Gambling Addiction Caused by Abilify, Lawsuit Charges
A recent product liability lawsuit filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. makes allegations that the companies
Learn MorePlaintiffs Ask That Abilify Compulsive Behavior Cases be Consolidated
Plaintiffs have asked the U.S. Judicial Panel on Multidistrict Litigation to consider transferring all federal Abilify compulsive behavior
Learn More